Variability in Mesalazine Management for Ulcerative Proctitis Include Doses, Route of Administration and Use of Fecal Calprotectin: Insights from Clinical Practice Across Spain Beyond Clinical Guidelines
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ceballos, D.
- Ricart, E.
- Marin-Jimenez, I.
- Menchen, L.
- Carpio, D.
- Ginard, D.
- Munoz, F.
- Gonzalez-Lama, Y.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Bastida,G,Ceballos,D,Ricart,E,Marin,I,Menchen,L,Carpio,D,Ginard,D et al. Variability in Mesalazine Management for Ulcerative Proctitis Include Doses, Route of Administration and Use of Fecal Calprotectin: Insights from Clinical Practice Across Spain Beyond Clinical Guidelines. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:OXFORD UNIV PRESS. 2024 p.p. 1840-1840.
Portal de investigación